Skip to search formSkip to main contentSkip to account menu

ellipticine

Known as: 5,11-dimethyl-6H-pyrido(4,3-b)carbazole 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
A special class of self-assembling peptides has been found to be capable of stabilizing the hydrophobic anticancer agent… 
2005
2005
The D816V activating mutation of the c-Kit kinase domain often causes human mastocytosis. Although inhibitors of wild-type c-Kit… 
2005
2005
Ellipticine is a potent antineoplastic agent, whose mode of action is considered to be based mainly on DNA intercalation and/or… 
2001
2001
Ellipticine derivatives have potential as anticancer drugs. Their clinical use has been limited, however, by poor solubility and… 
Highly Cited
2000
Highly Cited
2000
Treatment of 2-(1-alkynyl)phenyl isocyanates 6 with the iminophosphorane 14 produced in situ the benzoenynyl carbodiimides 15… 
1997
1997
The synthesis of a DNA-cutting agent that conjugates an ellipticine chromophore and a copper complex of bis(salicylidene… 
1992
1992
We have used DNA colony hybridization, the polymerase chain reaction (PCR), and direct DNA sequencing to determine the mutations… 
1992
1992
A bifunctional molecule in which an ellipticine chromophore is attached to a distamycin residue via a diaminopropyl tether has… 
Highly Cited
1991
Highly Cited
1991
Various antitumor drugs stabilize DNA topoisomerase II-DNA transient covalent complexes. The complexes distribution along pBR322… 
1986
1986
Installation of a basic side chain on the ring nitrogen of ellipticine did, as expected, improve the DNA binding properties of…